Development of Market Access Strategy

Aston Health has sufficient resources and experience to offer its clients the turnkey solutions for market access and pricing assessments:

• Conducting HTA analysis using own resources and in collaboration with the leading pharmacoeconomic institutions in this country
• Generating research information from Patient Registers in more than 20 disease areas
• Identifying regional potential in reimbursement segment: cross-analysis of sales data  (based on public tenders) and prescribing volumes (based on registry data) – Aston 360
• Pricing studies
• Developing Market Access Strategies on federal and regional levels
• Tracking changes in the Russian healthcare system – PharmCompass Россия and PharmCompass Регионы

In recent years, the Russian pharmaceutical market has been undergoing significant changes, especially with respect to public regulation and funding, which had a significant impact on market entry strategies.

Market Access and HTA are playing an increasing role in the commercial success of marketed drugs, medical devices and equipment in the region-specific environment.

This requires industry players to focus on obtaining proper and timely insights on regulatory and funding changes at federal and regional level.